Inhibition of lung colonisation of a mouse mammary carcinoma by therapeutic vaccination with interferon-α gene-transduced tumor cells

Clinical and Experimental Metastasis

Volumn 16, Issue 2, 1998, Pages 123-128

  Rossi, Ilaria ^a   Nicoletti, Giordano ^a,b   Landuzzi, Lorena ^a,b   Frabetti, Flavia ^a   De Giovanni, Carla ^a   Nanni, Patrizia ^a   Musiani, Piero ^c   Ferrantini, Maria ^d   Belardelli, Filippo ^d   Lollini, Pier Luigi ^a,e  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b INSTITUTO SUPERIOR TÉCNICO   (Portugal)

^c UNIVERSITY OF CHIETI   (Italy)

^d ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^e Cancer Research Center   (Italy)

Author keywords

Gene therapy; Interferon alpha; Interferon gamma; Lung colony assay; Mouse mammary carcinoma; Vaccination

Indexed keywords

ALPHA INTERFERON; CANCER VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CARCINOMA; CANCER IMMUNIZATION; FEMALE; GENE TARGETING; GENE THERAPY; HOST RESISTANCE; INTERFERON PRODUCTION; LUNG METASTASIS; METASTASIS INHIBITION; MOUSE; NONHUMAN; NUDE MOUSE; TUMOR REJECTION;

ADENOCARCINOMA; ANIMALS; CANCER VACCINES; FEMALE; INJECTIONS, INTRAPERITONEAL; INJECTIONS, INTRAVENOUS; INJECTIONS, SUBCUTANEOUS; INTERFERON TYPE II; INTERFERON-ALPHA; LUNG NEOPLASMS; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, INBRED BALB C; MICE, NUDE; MITOMYCIN; T-LYMPHOCYTES; TRANSDUCTION, GENETIC;

EID: 15444350657     PISSN: 02620898     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1021980818017     Document Type: Article

References (23)

1. Gilmour KC and Reich NC, 1995, Signal transduction and activation of gene transcription by interferons. Gene Expression, 5, 1-18.
2. DeVita VT, Hellman S and Rosenberg SA, 1995, Biologic Therapy of Cancer. Lippincott, Philadelphia,
3. Pujade-Lauraine E, Guastalla JP, Colombo N, et al. 1996, Intraperitoneal recombinant interferon gamma in ovarian cancer patients with residual disease at second-look laparotomy. J Clin Oncol, 14, 343-50.
4. Lollini P-L, Nanni P, De Giovanni C, Nicoletti G and Landuzzi L, 1996, Re: "Randomized trial of adjuvant human interferon gamma versus observation in high-risk cutaneous melanoma: a Southwest Oncology Group study" (letter). J Natl Cancer Inst, 88, 926-7.
5. Forni G, Cavallo F, Consalvo M, et al. 1995, Molecular approaches to cancer immunotherapy. Cytokines Mol Ther, 1, 225-48.
6. Musiani P, Allione A, Modica A, et al. 1996, Role of neutrophils and lymphocytes in inhibition of a mouse mammary adenocarcinoma engineered to release IL-2, IL-4, IL-7, IL-10, IFN-alpha, IFN-gamma, and TNF-alpha. Lab Invest, 74, 146-57.
7. Musiani P, Modesti A, Giovarelli M, et al., 1996, Cytokines, tumor cell death and immunogenicity: a question of choice. Immunol Today, 18, 32-6.
8. Ferrantini M, Giovarelli M, Modesti A, et al. 1994, IFN-alpha 1 gene expression into a metastatic murine adenocarcinoma (TS/A) results in CD8+ T cell-mediated tumor rejection and development of antitumor immunity. Comparative studies with IFN-gamma producing TS/A cells. J Immunol, 153, 4604-15.
9. Lollini P-L, Bosco MC, Cavallo F, et al. 1993, Inhibition of tumor growth and enhancement of metastasis after transfection of the gamma-interferon gene. Int J Cancer, 55, 320-29.
10. Nanni P, De Giovanni C, Lollini P-L, Nicoletti G and Prodi G, 1983, TS/A: a new metastasizing cell line from a BALB/c spontaneous mammary adenocarcinoma. Clin Exp Metastasis, 1, 373-80.
11. Colombo MP and Forni G, 1994, Cytokine gene transfer in tumor inhibition and tumor therapy: where are we now? Immunol Today, 15, 48-51.
12. Allione A, Consalvo M, Nanni P, et al. 1994, Immunizing and curative potential of replicating and nonreplicating murine mammary adenocarcinoma cells engineered with IL2, IL4, IL6, IL7, IL10, TNF-alpha, GM-CSF and IF-gamma gene or admixed with conventional adjuvants. Cancer Res, 54, 6022-6.
13. Wexler H, 1966, Accurate identification of experimental pulmonary metastases. J Natl Cancer Inst, 36, 641-5.
14. Nanni P, De Giovanni C, Landuzzi L, et al. 1996, Therapy of murine mammary carcinoma metastasis with interferon gamma and MHC gene-transduced tumor cells. Br J Cancer, 74, 1564-9.
15. Kundig TM, Bachmann MF, DiPaolo C, et al. 1995, Fibroblasts as efficient antigen-presenting cells in lymphoid organs. Science, 268, 1343-7.
16. Belardelli F, 1995, Role of interferons and other cytokines in the regulation of the immune response. APMIS, 103, 161-79.
17. Belardelli F and Gresser I, 1996, The neglected role of type I interferon in the T cell response: implications for its clinical use. Immunol Today, 17, 369-72.
18. Inaha K, Kitaura M, Kato T, Watanabe Y, Kawade Y and Muramatsu S, 1986, Contrasting effect of alfa/beta and gamma-interferons on expression of macrophage Ia antigens. J Exp Med, 163, 1030-5.
19. Ling PD, Warren MK and Vogel SN, 1985, Antagonistic effect of interferon-beta on the interferon-gamma-induced expression of Ia antigen in murine macrophages. J Immunol, 135, 1857-63.
20. Garotta G, Talmadge KW, Richard J, Pink L, Dewald B and Baggiolini M, 1986, Functional antagonism between type I and type II interferons on human macrophages. Biochem Biophys Res Commun, 140, 948-54.
21. Testa U, Conti L, Sposi NM, et al. 1995, IFN-beta selectively down regulates transferrin receptor expression in human peripheral blood macrophages by a post-translational mechanism. J Immunol, 155, 427-35.
22. Ramani P and Balkwill FR, 1987, Enhanced metastases of a mouse carcinoma after in vitro treatment with murine IFN gamma. Int J Cancer, 40, 830-4.
23. Kelly SA, Gschmeissner S, East N and Balkwill FR, 1991, Enhancement of metastatic potential by gamma-interferon. Cancer Res, 51, 4020-7.